Bullous pyoderma gangrenosum secondary to underlying multiple myeloma: treated with ciclosporin

Affiliations

¹ Department ofDermatology, Venereology and Leprology, Postgraduate Institute of Medical Education and Research (PGIMER), Sector 12, Chandigarh, 160012, India.
² Department of Internal Medicine and Haemato-Oncology, Postgraduate Institute of Medical Education and Research (PGIMER), Sector 12, Chandigarh, 160012, India.
³ Department of Haemato-Pathology, Postgraduate Institute of Medical Education and Research (PGIMER), Sector 12, Chandigarh, 160012, India.
⁴ Department of Histopathology, Postgraduate Institute of Medical Education and Research (PGIMER), Sector 12, Chandigarh, 160012, India.
⁵ Department of Immunopathology, Postgraduate Institute of Medical Education and Research (PGIMER), Sector 12, Chandigarh, 160012, India.

Case Reports

M Razmi T et al. Clin Exp Dermatol. 2019 Mar.

. 2019 Mar;44(2):e13-e15.

doi: 10.1111/ced.13804. Epub 2018 Oct 7.

¹ Department ofDermatology, Venereology and Leprology, Postgraduate Institute of Medical Education and Research (PGIMER), Sector 12, Chandigarh, 160012, India.
² Department of Internal Medicine and Haemato-Oncology, Postgraduate Institute of Medical Education and Research (PGIMER), Sector 12, Chandigarh, 160012, India.
³ Department of Haemato-Pathology, Postgraduate Institute of Medical Education and Research (PGIMER), Sector 12, Chandigarh, 160012, India.
⁴ Department of Histopathology, Postgraduate Institute of Medical Education and Research (PGIMER), Sector 12, Chandigarh, 160012, India.
⁵ Department of Immunopathology, Postgraduate Institute of Medical Education and Research (PGIMER), Sector 12, Chandigarh, 160012, India.

No abstract available

Comment in

Comment on 'Bullous pyoderma gangrenosum secondary to underlying multiple myeloma: treated with ciclosporin'.
Mathivanan BR, Singh S, Bardia A, Nalwa A. Mathivanan BR, et al. Clin Exp Dermatol. 2019 Oct;44(7):e245-e246. doi: 10.1111/ced.14019. Epub 2019 Jul 8. Clin Exp Dermatol. 2019. PMID: 31162845 No abstract available.